Santiago Hernández-Allés
University of the Balearic Islands
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Santiago Hernández-Allés.
Antimicrobial Agents and Chemotherapy | 1999
Luis Martínez-Martínez; Álvaro Pascual; Santiago Hernández-Allés; Dolores Alvarez-Díaz; Ana Isabel Suárez; John H. Tran; Vicente J. Benedí; George A. Jacoby
ABSTRACT Two clinical isolates of extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae were noted to be less susceptible than expected to imipenem. Both were missing outer membrane proteins that serve as channels for antibiotic entry. The role of β-lactamase in resistance was investigated by eliminating the original ESBL and introducing plasmids encoding various ESBLs and AmpC β-lactamase types, by studying the effect of an increased inoculum, and by evaluating interactions with β-lactamase inhibitors. The contribution of porin deficiency was investigated by restoring a functional ompK36 gene on a plasmid. Plasmids encoding AmpC-type β-lactamases provided resistance to imipenem (up to 64 μg/ml) and meropenem (up to 16 μg/ml) in strains deficient in porins. Carbapenem resistance showed little inoculum effect, was not affected by clavulanate but was blocked by BRL 42715, and was diminished if OmpK36 porin was restored. Plasmids encoding TEM- and SHV-type ESBLs conferred resistance to cefepime and cefpirome, as well as to earlier oxyimino-β-lactams. This resistance was magnified with an increased inoculum, was blocked by clavulanate, and was also lowered by OmpK36 porin restoration. In addition, SHV-2 β-lactamase had a small effect on carbapenem resistance (imipenem MIC, 4 μg/ml, increasing to 16 μg/ml with a higher inoculum) when porins were absent. In K. pneumoniae porin loss can thus augment resistance provided either by TEM- or SHV-type ESBLs or by plasmid-mediated AmpC enzymes to include the latest oxyimino-β-lactams and carbapenems.
Microbiology | 1999
Santiago Hernández-Allés; Sebastián Albertí; Dolores Álvarez; Antonio Doménech-Sánchez; Luis Martínez-Martínez; José A. Gil; Juan M. Tomás; Vicente J. Benedí
Two porins, OmpK36 and OmpK35, have been described previously in Klebsiella pneumoniae, and they are homologous to the Escherichia coli porins OmpC and OmpF, respectively, at both the DNA and amino acid levels. Optimal resolution of the two K. pneumoniae porins by electrophoresis on polyacrylamide gels is not achieved using gel systems already described for E. coli and requires modifications of the bisacrylamide content of the resolving gels. Once resolved, identification of porins OmpK36 and OmpK35 cannot be based solely on their apparent molecular masses since in some strains the OmpK36 porin migrates faster than the OmpK35 porin, whilst in other strains OmpK35 is the faster-migrating porin. Expression of OmpK35 porin is increased in low-osmolarity medium and, combined with Western blot analysis, this allows for the identification of both porins. Application of this identification system showed that most isolates lacking expression of extended-spectrum beta-lactamases express the two porins, whereas most isolates producing these beta-lactamases express only porin OmpK36, and the OmpK35 porin is either very low or not expressed.
Antimicrobial Agents and Chemotherapy | 1996
Luis Martínez-Martínez; Santiago Hernández-Allés; Sebastián Albertí; Juan M. Tomás; Vicente J. Benedí; George A. Jacoby
Journal of Clinical Microbiology | 1999
Dennis S. Hansen; Francesca Mestre; Sebastián Albertí; Santiago Hernández-Allés; Dolores Álvarez; Antonio Doménech-Sánchez; José A. Gil; Susana Merino; Juan M. Tomás; Vicente J. Benedí
Antimicrobial Agents and Chemotherapy | 1998
Carmen Ardanuy; Josefina Liñares; M.A. Dominguez; Santiago Hernández-Allés; Vicente J. Benedí; Luis Martínez-Martínez
Journal of Antimicrobial Chemotherapy | 2000
Santiago Hernández-Allés; María del Carmen Conejo; Álvaro Pascual; Juan M. Tomás; Vicente J. Benedí; Luis Martínez-Martínez
Antimicrobial Agents and Chemotherapy | 1999
Santiago Hernández-Allés; Vicente J. Benedí; Luis Martínez-Martínez; Álvaro Pascual; Alicia Aguilar; Juan M. Tomás; Sebastián Albertí
Journal of Bacteriology | 1999
Antonio Doménech-Sánchez; Santiago Hernández-Allés; Luis Martínez-Martínez; Vicente J. Benedí; Sebastián Albertí
Infection and Immunity | 1996
Sebastián Albertí; Guillermo Marqués; Santiago Hernández-Allés; Xavier Rubires; Juan M. Tomás; Vicente J. Benedí
Antimicrobial Agents and Chemotherapy | 1998
Luis Martínez-Martínez; Isabel García; Sofía Ballesta; Vicente J. Benedí; Santiago Hernández-Allés; Álvaro Pascual